Lifescience Reagent Market Challenges with Forecast to 2028 : Analysis, Drivers

Lifescience Reagent Market
GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND
OPPORTUNITY ANALYSIS, 2018-2026
REPORT DESCRIPTION
Lifescience Reagent Market – Overview
Increasing prevalence of infectious disease, which requires early diagnosis is creating the opportunity for
the biotechnology industry players to produce effective reagents to carry out various diagnostic tests.
Moreover, launching of new diagnostic tests and assays is contributing to the lifescience reagents market
share. For instance, in April 2019, Roche launched Ventana HER2 Dual ISH DNA Probe Cocktail assay for
the detection of the HER2 biomarker in breast and gastric cancer patients to determine the eligibility for the
targeted drug trastuzumab (Herceptin). The new reagent is intended for in vitro diagnostic (IVD) use.
The global lifescience reagent market was valued at US$ 33,754.0 million in 2017, and is expected to
witness a CAGR of 7.3% during the forecast period (2018–2026).
Increasing product launches for reagents to assist different types of diagnostics tests and research purpose
is expected to drive the global lifescience reagent market growth. For instance, in March 2019, Dolomite
Bio, a provider of single cell technologies, launched a new scRNA-Seq reagent kit to expand the Nadia
Instrument portfolio. The new scRNA-Seq reagent kit is designed to enable the generation of PCR
amplified cDNA libraries on the Nadia Instrument, allowing high throughput gene expression profiling of
heterogeneous cell populations.
REPORT DESCRIPTION
Lifescience Reagent Market – Dynamics
Increasing product launch of lifescience reagents that are widely used in biological research purpose is
expected to drive global lifescience reagent market growth. For instance, in July 2018, Ultivue, Inc.
launched UltiMapper portfolio of reagents. The portfolio includes a fully optimized, ready-to-use portfolio
of kits enabling fast, holistic profiling and characterization of tumor immuno-oncology markers in
Formalin-Fixed, Paraffin-Embedded (FFPE) samples. The novel approach enabled tissue marker detection
and analysis at high level of multiplexing and throughput, using instrumentation and software solutions
currently used in most Immuno-Histochemistry laboratories.
Moreover, in March 2018, Torax Medical, Inc. launched B2B IVD bulk reagents for Latex Serology and
Blood Grouping assays. In February 2019, Illumina, Inc. introduced new reagent kit, NovaSeq 6000 S
Prime (SP) Reagent Kits, that enables configuration of smaller batch sizes and lower output sequencing
methods at a lower price per read compared to NextSeq or HiSeq Systems.
Download PDF Brochure @
https://www.coherentmarketinsights.com/insight/request-pdf/2681
REPORT DESCRIPTION
Lifescience Reagent Market – Key Players
•
•
•
•
•
•
•
•
•
•
•
F. Hoffmann-La Roche Ltd.
Danaher Corporation
Abbott Laboratories
Merck KgaA
Bio-Rad Laboratories
GE Healthcare
Siemens Healthineers
Becton
Dickinson and Company
Agilent Technologies Inc.
Perkin Elmer
Read More @
https://www.coherentmarketinsights.com/market-insight/lifescience-reagent-market-2681
ABOUT COHERENT MARKET INSIGHTS
ABOUT US
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its
plethora of clients achieve transformational growth by helping them make critical business decisions. We are
headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players
from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help
businesses around the globe deliver practical and lasting results through various recommendations about
operational improvements, technologies, emerging market trends and new working methods. We offer both
customized and syndicated market research reports that help our clients create visionary growth plans to
provide traction to their business. We meticulously study emerging trends across various industries at both the
global and regional levels to identify new opportunities for our clientele.
SERVICES
INDUSTRY ANALYSIS
MARKET INTELLIGENCE SERVICES
CUSTOMIZED RESEARCH
SYNDICATED RESEARCH
CONSULT STUDIES
COUNTRY SPECIFIC STUDIES
ABOUT CMI
SECTOR
COVERAGE
BIOTECHNOLOGY
MEDICAL DEVICES




CLINICAL
DIAGNOSTIC
MEDICAL IMAGING
Global Leading Equipment and System Manufacturers
Component Providers and System Integrators
Distributors, Retailors and Value Added Resellers
Healthcare IT Solutions Developers
Marketing Consultancies and the Advertising Industry
 Private and Government organization
 Outsourcing Companies
 Universities and Business Schools.
HEALTHCARE IT
PHARMACEUTICAL
ABOUT US
KEY STATS
100
+
150+
RESEARCH
SOLUTIONS
FEASIBILITY
STUDIES
GLOBAL
REPORTS
Insights Published Per Year
Consulting Projects Till
Date
125+
Clients Worldwide Per Year
110+
COUNTRY
ANALYSIS
CONSULT
PROJECTS
SURVEY
RESEARCH
EXCEL
FORECAST
DATABASE
COMPETITIVE
ASSESSMENT
TECHNOLOGY
SNIPPETS
Analysts and Contract
Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including
chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in
the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various
industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely
designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed
markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein.
THANK YOU
To know more about us, visit our website:
www.coherentmarketinsights.com
For sales queries or new topics email us on:
sales@coherentmarketinsights.com
For other queries contact:
Mr. Shah
(Manager - Business Development)
Coherent Market Insights
sales@coherentmarketinsights.com
+1-206-701-6702

Asia Pacific is also expected to drive the global lifescience reagent market growth, owing to presence of key players in this regions.